These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2064631)

  • 1. LDL-apheresis: results of longterm treatment and vascular outcome.
    Keller C
    Atherosclerosis; 1991 Jan; 86(1):1-8. PubMed ID: 2064631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of low density lipoprotein apheresis in the treatment of familial hypercholesterolemia.
    Thompson GR; Kitano Y
    Ther Apher; 1997 Feb; 1(1):13-6. PubMed ID: 10225774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LDL cholesterol apheresis by dextran sulfate cellulose adsorption. Long-term experience in patients with familial hypercholesterolemia.
    Olbricht CJ; Schulzeck P
    ASAIO Trans; 1991; 37(3):M492-3. PubMed ID: 1751248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
    Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
    Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood rheology after LDL apheresis using dextran sulfate cellulose absorption--a case report.
    Koenig W; Ditschuneit HH; Hehr R; Grunewald RW; Ernst E; Hombach V
    Angiology; 1992 Jul; 43(7):606-9. PubMed ID: 1626740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
    Lee WP; Datta BN; Ong BB; Rees A; Halcox J
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.
    Koizumi J; Koizumi I; Uno Y; Inazu A; Kajinami K; Haraki T; Yagi K; Kamon N; Miyamoto S; Takegoshi T
    Atherosclerosis; 1993 Apr; 100(1):65-74. PubMed ID: 8318064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study Group.
    Gordon BR; Kelsey SF; Bilheimer DW; Brown DC; Dau PC; Gotto AM; Illingworth DR; Jones PH; Leitman SF; Prihoda JS
    Am J Cardiol; 1992 Oct; 70(11):1010-6. PubMed ID: 1414897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative and technical assessment of the HELP system (heparin extracorporeal LDL precipitation) and cascade filtration (CF) for the treatment of high plasma lipids].
    Loschiavo C
    G Ital Nefrol; 2013; 30(3):. PubMed ID: 23832475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal LDL-cholesterol elimination in the treatment of severe familial hypercholesterolemia.
    Bláha M
    Acta Medica (Hradec Kralove); 2003; 46(1):3-7. PubMed ID: 12747532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of cascade filtration plasmapheresis in two patients affected by familial hypercholesterolemia.
    Barbagallo CM; Averna MR; DiMarco T; Spano L; Scafidi V; Marino G; Camemi AR; Notarbartolo A
    J Clin Apher; 1995; 10(2):96-100. PubMed ID: 7592525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis.
    McGowan MP
    J Clin Lipidol; 2013; 7(3 Suppl):S21-6. PubMed ID: 23642325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient.
    Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K
    Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-dietary, non-pharmacological treatment of severe hypercholesterolemia].
    Hansen PS; Sølling J; Knudsen TE; Faergeman O
    Ugeskr Laeger; 1991 Jul; 153(29):2046-51. PubMed ID: 1858184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo rheologic effects of lipid apheresis techniques: comparison of dextran sulfate LDL adsorption and heparin induced LDL precipitation.
    Grützmacher P; Landgraf H; Esser R; Okon J; Vlachojannis J; Ehrly AM; Schoeppe W
    ASAIO Trans; 1990; 36(3):M327-30. PubMed ID: 2252691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radical therapy of refractory hyperlipidemia: extracorporeal cholesterol elimination].
    Kostner KM
    Wien Med Wochenschr; 1994; 144(12-13):333-5. PubMed ID: 8650940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of different low-density lipoprotein apheresis methods.
    Parhofer KG; Geiss HC; Schwandt P
    Ther Apher; 2000 Oct; 4(5):382-5. PubMed ID: 11111821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [LDL apheresis in the treatment of familial hypercholesterolemia].
    Coker M
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():32-46. PubMed ID: 25693361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis].
    Schuff-Werner P
    Z Kardiol; 1997; 86 Suppl 1():57-64. PubMed ID: 9173722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
    Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
    Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.